SUVRETTA CAPITAL MANAGEMENT, LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
12:00 pm
Purchase
2023-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
SUVRETTA CAPITAL MANAGEMENT, LLC4,774,389
9.990%
1,363,179increase
(+39.96%)
Filing
History
2024-02-13
11:55 am
Purchase
2023-12-3113GKezar Life Sciences, Inc.
KZR
SUVRETTA CAPITAL MANAGEMENT, LLC716,759
9.900%
366,333increase
(+104.54%)
Filing
History
2024-02-13
11:50 am
Purchase
2023-12-3113GArcellx, Inc.
ACLX
SUVRETTA CAPITAL MANAGEMENT, LLC2,435,974
5.000%
85,641increase
(+3.64%)
Filing
History
2024-02-13
11:44 am
Purchase
2023-12-3113GTerns Pharmaceuticals, Inc.
TERN
SUVRETTA CAPITAL MANAGEMENT, LLC5,837,126
9.500%
2,388,851increase
(+69.28%)
Filing
History
2024-02-05
4:43 pm
Purchase
2024-01-2613GCogent Biosciences, Inc.
COGT
SUVRETTA CAPITAL MANAGEMENT, LLC5,481,034
6.400%
5,481,034increase
(New Position)
Filing
History
2023-10-30
5:03 pm
Purchase
2023-10-2013GArcutis Biotherapeutics, Inc.
ARQT
SUVRETTA CAPITAL MANAGEMENT, LLC9,592,212
9.990%
9,592,212increase
(New Position)
Filing
History
2023-10-30
5:02 pm
Purchase
2023-10-1813G89bio, Inc.
ETNB
SUVRETTA CAPITAL MANAGEMENT, LLC4,808,374
6.400%
4,808,374increase
(New Position)
Filing
History
2023-06-15
4:31 pm
Purchase
2023-06-0513GZura Bio Limited
ZURA
SUVRETTA CAPITAL MANAGEMENT, LLC2,850,000
6.600%
2,850,000increase
(New Position)
Filing
History
2023-04-24
4:47 pm
Purchase
2023-04-1213GInflaRx N.V.
IFRX
SUVRETTA CAPITAL MANAGEMENT, LLC5,733,910
10.300%
3,587,670increase
(+167.16%)
Filing
History
2023-04-18
4:16 pm
Sale
2022-12-3113GBenitec Biopharma Inc.
BNTC
SUVRETTA CAPITAL MANAGEMENT, LLC177,660
9.990%
-194,617decrease
(-52.28%)
Filing
History
2023-03-10
5:15 pm
Purchase
2023-01-2513GKalVista Pharmaceuticals, Inc.
KALV
SUVRETTA CAPITAL MANAGEMENT, LLC1,796,379
5.300%
724,077increase
(+67.53%)
Filing
History
2023-02-13
4:37 pm
Purchase
2022-12-3113GProKidney Corp.
PROK
SUVRETTA CAPITAL MANAGEMENT, LLC6,280,175
10.200%
10,875increase
(+0.17%)
Filing
History
2023-02-13
1:44 pm
Unchanged
2022-12-3113GDisc Medicine, Inc.
IRON
SUVRETTA CAPITAL MANAGEMENT, LLC0
0.000%
0
(Unchanged)
Filing
History
2023-02-13
1:31 pm
Purchase
2022-12-3113GBiohaven Ltd.
BHVN
SUVRETTA CAPITAL MANAGEMENT, LLC3,848,938
5.700%
8,600increase
(+0.22%)
Filing
History
2023-02-13
1:21 pm
Sale
2022-12-3113GMereo BioPharma Group plc
MREO
SUVRETTA CAPITAL MANAGEMENT, LLC36,822,190
5.900%
-8,888,145decrease
(-19.44%)
Filing
History
2023-02-13
1:07 pm
Purchase
2022-12-3113GKura Oncology, Inc.
KURA
SUVRETTA CAPITAL MANAGEMENT, LLC6,376,815
9.300%
2,804,396increase
(+78.50%)
Filing
History
2023-02-13
12:36 pm
Sale
2022-12-3113GBolt Biotherapeutics, Inc.
BOLT
SUVRETTA CAPITAL MANAGEMENT, LLC0
0.000%
-111,513decrease
(Position Closed)
Filing
History
2023-02-13
12:25 pm
Purchase
2022-12-3113GBenitec Biopharma Inc.
BNTC
SUVRETTA CAPITAL MANAGEMENT, LLC372,276
9.990%
327,041increase
(+722.98%)
Filing
History
2023-02-13
12:01 pm
Sale
2022-12-3113GInflaRx N.V.
IFRX
SUVRETTA CAPITAL MANAGEMENT, LLC2,146,240
4.900%
-4,138,760decrease
(-65.85%)
Filing
History
2023-02-13
10:56 am
Purchase
2022-12-3113GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT, LLC5,565,099
9.700%
3,091,304increase
(+124.96%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, 7, Next